Trial Profile
Effect of ASV and DCV therapy on the quality of immune status in chronic HCV patients Investigator initiated research proposal nr. AI447-108
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2014
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms Immuno-Dual
- 04 Mar 2014 New trial record